Preliminary study on the safety and efficacy of a new polymyxin B‐immoblized resin column in treatment of LPS‐induced sepsis beagles

Abstract Background This study aims to assess the safety and efficacy of direct hemoperfusion using a new polymyxin B‐immobilized resin column (disposable endotoxin adsorber, KCEA) in an endotoxin/ lipopolysaccharide (LPS)‐induced sepsis model. Methods Eighteen beagles were randomized into 1 interve...

Full description

Bibliographic Details
Main Authors: Yonggui Li, Zhenggen Yang, Jialiang Hu, Zhennan Lin
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Animal Models and Experimental Medicine
Subjects:
Online Access:https://doi.org/10.1002/ame2.12199
_version_ 1818274528467353600
author Yonggui Li
Zhenggen Yang
Jialiang Hu
Zhennan Lin
author_facet Yonggui Li
Zhenggen Yang
Jialiang Hu
Zhennan Lin
author_sort Yonggui Li
collection DOAJ
description Abstract Background This study aims to assess the safety and efficacy of direct hemoperfusion using a new polymyxin B‐immobilized resin column (disposable endotoxin adsorber, KCEA) in an endotoxin/ lipopolysaccharide (LPS)‐induced sepsis model. Methods Eighteen beagles were randomized into 1 intervention group (KCEA group, n = 6) and 2 control groups (sham group and model group, n = 6 each). Sepsis was induced by continuous intravenous application of 0.5 mg/kg body weight of endotoxin for 60 min. An extracorporeal hemoperfusion device made with KCEA for endotoxin adsorption was used. Model group beagles received standard treatment with fluids and vasoactive drugs, KCEA group beagles received standard treatment and direct hemoperfusion of KCEA for 2 h, and sham group beagles were treated with standard treatment and direct hemoperfusion of a sham column for 2 h. Results Good blood compatibility of KCEA was confirmed by assessing clinical parameters. Blood endotoxin peak levels in the KCEA group were significantly lower, resulting in a significant suppression of IL‐6, TNF‐α and procalcitonin, which improved mean arterial pressure and significantly lowered vasopressor demand, thereby protecting organ function and improving survival time and rate. In the KCEA group, MAP was significantly higher over 6 h than those recorded both in the sham group and model group. The 7‐day survival rates of the KCEA, sham and model groups were 50%, 0% and 0%, respectively. Conclusion KCEA hemoadsorption was effective at detoxifying circulatory endotoxin and inflammatory mediators and contributed to the decreased mortality rate in the sepsis beagles.
first_indexed 2024-12-12T22:15:17Z
format Article
id doaj.art-17a2d52833a34bb29e191111c14351ff
institution Directory Open Access Journal
issn 2576-2095
language English
last_indexed 2024-12-12T22:15:17Z
publishDate 2022-04-01
publisher Wiley
record_format Article
series Animal Models and Experimental Medicine
spelling doaj.art-17a2d52833a34bb29e191111c14351ff2022-12-22T00:10:05ZengWileyAnimal Models and Experimental Medicine2576-20952022-04-015216117110.1002/ame2.12199Preliminary study on the safety and efficacy of a new polymyxin B‐immoblized resin column in treatment of LPS‐induced sepsis beaglesYonggui Li0Zhenggen Yang1Jialiang Hu2Zhennan Lin3Research and Development Center Guangzhou Koncen Bioscience Co., Ltd. Guangzhou PR ChinaResearch and Development Center Guangzhou Koncen Bioscience Co., Ltd. Guangzhou PR ChinaResearch and Development Center Guangzhou Koncen Bioscience Co., Ltd. Guangzhou PR ChinaResearch and Development Center Guangzhou Koncen Bioscience Co., Ltd. Guangzhou PR ChinaAbstract Background This study aims to assess the safety and efficacy of direct hemoperfusion using a new polymyxin B‐immobilized resin column (disposable endotoxin adsorber, KCEA) in an endotoxin/ lipopolysaccharide (LPS)‐induced sepsis model. Methods Eighteen beagles were randomized into 1 intervention group (KCEA group, n = 6) and 2 control groups (sham group and model group, n = 6 each). Sepsis was induced by continuous intravenous application of 0.5 mg/kg body weight of endotoxin for 60 min. An extracorporeal hemoperfusion device made with KCEA for endotoxin adsorption was used. Model group beagles received standard treatment with fluids and vasoactive drugs, KCEA group beagles received standard treatment and direct hemoperfusion of KCEA for 2 h, and sham group beagles were treated with standard treatment and direct hemoperfusion of a sham column for 2 h. Results Good blood compatibility of KCEA was confirmed by assessing clinical parameters. Blood endotoxin peak levels in the KCEA group were significantly lower, resulting in a significant suppression of IL‐6, TNF‐α and procalcitonin, which improved mean arterial pressure and significantly lowered vasopressor demand, thereby protecting organ function and improving survival time and rate. In the KCEA group, MAP was significantly higher over 6 h than those recorded both in the sham group and model group. The 7‐day survival rates of the KCEA, sham and model groups were 50%, 0% and 0%, respectively. Conclusion KCEA hemoadsorption was effective at detoxifying circulatory endotoxin and inflammatory mediators and contributed to the decreased mortality rate in the sepsis beagles.https://doi.org/10.1002/ame2.12199endotoxinhemoadsorptionpolymyxin B sulfateresinsepsis
spellingShingle Yonggui Li
Zhenggen Yang
Jialiang Hu
Zhennan Lin
Preliminary study on the safety and efficacy of a new polymyxin B‐immoblized resin column in treatment of LPS‐induced sepsis beagles
Animal Models and Experimental Medicine
endotoxin
hemoadsorption
polymyxin B sulfate
resin
sepsis
title Preliminary study on the safety and efficacy of a new polymyxin B‐immoblized resin column in treatment of LPS‐induced sepsis beagles
title_full Preliminary study on the safety and efficacy of a new polymyxin B‐immoblized resin column in treatment of LPS‐induced sepsis beagles
title_fullStr Preliminary study on the safety and efficacy of a new polymyxin B‐immoblized resin column in treatment of LPS‐induced sepsis beagles
title_full_unstemmed Preliminary study on the safety and efficacy of a new polymyxin B‐immoblized resin column in treatment of LPS‐induced sepsis beagles
title_short Preliminary study on the safety and efficacy of a new polymyxin B‐immoblized resin column in treatment of LPS‐induced sepsis beagles
title_sort preliminary study on the safety and efficacy of a new polymyxin b immoblized resin column in treatment of lps induced sepsis beagles
topic endotoxin
hemoadsorption
polymyxin B sulfate
resin
sepsis
url https://doi.org/10.1002/ame2.12199
work_keys_str_mv AT yongguili preliminarystudyonthesafetyandefficacyofanewpolymyxinbimmoblizedresincolumnintreatmentoflpsinducedsepsisbeagles
AT zhenggenyang preliminarystudyonthesafetyandefficacyofanewpolymyxinbimmoblizedresincolumnintreatmentoflpsinducedsepsisbeagles
AT jialianghu preliminarystudyonthesafetyandefficacyofanewpolymyxinbimmoblizedresincolumnintreatmentoflpsinducedsepsisbeagles
AT zhennanlin preliminarystudyonthesafetyandefficacyofanewpolymyxinbimmoblizedresincolumnintreatmentoflpsinducedsepsisbeagles